Advertisement

Investigational New Drugs

, Volume 37, Issue 6, pp 1309–1309 | Cite as

Correction to: Sphingadienes show therapeutic efficacy in neuroblastoma in vitro and in vivo by targeting the AKT signaling pathway

  • Piming Zhao
  • Ana E. Aguilar
  • Joanna Y. Lee
  • Lucy A. Paul
  • Jung H. Suh
  • Latika Puri
  • Meng Zhang
  • Jennifer Beckstead
  • Andrzej Witkowski
  • Robert O. Ryan
  • Julie D. SabaEmail author
Correction
  • 370 Downloads

Correction to: Investigational New Drugs (2018) 36:743–754

  https://doi.org/10.1007/s10637-017-0558-5

The authors would like to note an omission of disclosure in this paper. Author JDS is cofounder, equity-holder, and consultant of GILTRx Therapeutics.

Notes

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Piming Zhao
    • 1
  • Ana E. Aguilar
    • 1
    • 2
  • Joanna Y. Lee
    • 1
  • Lucy A. Paul
    • 1
  • Jung H. Suh
    • 1
  • Latika Puri
    • 1
    • 3
  • Meng Zhang
    • 1
  • Jennifer Beckstead
    • 1
  • Andrzej Witkowski
    • 1
  • Robert O. Ryan
    • 1
  • Julie D. Saba
    • 1
    Email author
  1. 1.UCSF Benioff Children’s Hospital OaklandChildren’s Hospital Oakland Research InstituteOaklandUSA
  2. 2.Arnold Palmer Hospital for ChildrenOrlandoUSA
  3. 3.St Jude Children’s Research HospitalMemphisUSA

Personalised recommendations